Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies Post author:Sam Post published:December 13, 2017 Post category:BioPharma Investors were Atlas Venture and OrbiMed. Source: BioSpace You Might Also Like Bicycle Therapeutics Snags $52 Million to Take Early Stage Drugs Into Clinic May 31, 2017 Eli Lilly’s Verzenio Picks Up Third Approved Indication February 26, 2018 AstraZeneca PLC Jumps Deeper Into mRNA Drugs With Ethris Deal August 20, 2017
